Share on LinkedInShare on LinkedIn

ARTICLE · 03 APRIL 2014

ESMA Issues Updated EMIR Q&A

GVZH Advocates
GVZH Advocates
Contributor
GVZH Advocates

GVZH Advocates

GVZH Advocates is a modern and sophisticated legal practice comprised of top-tier professionals,...

View firm profile
Explore more from GVZH Advocates

The ESMA has issued an updated Q&A in relation to the Implementation of the Regulation on OTC derivatives, central counterparties and trade repositories (EMIR).

European UnionCorporate/Commercial Law

On 20th March 2014 ESMA, the European Securities and Markets Authority, has issued an updated Questions and Answers document in relation to the Implementation of the Regulation (EU) No 648/2012 on OTC derivatives, central counterparties and trade repositories (EMIR).

Access to this document may be found through the following Link, however this document is intended to be continuously updated with any questions received by ESMA.

www.csb-advocates.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from